BlackRock Investment Management’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $500K | Sell |
96,621
-1,854
| -2% | -$9.59K | ﹤0.01% | 3036 |
|
|
2016
Q3 | $549K | Buy |
98,475
+9,102
| +10% | +$50.7K | ﹤0.01% | 2984 |
|
|
2016
Q2 | $496K | Buy |
89,373
+20,843
| +30% | +$116K | ﹤0.01% | 3061 |
|
|
2016
Q1 | $302K | Buy |
68,530
+279
| +0.4% | +$1.23K | ﹤0.01% | 3061 |
|
|
2015
Q4 | $411K | Buy |
68,251
+9,459
| +16% | +$57K | ﹤0.01% | 3052 |
|
|
2015
Q3 | $460K | Buy |
58,792
+2,260
| +4% | +$17.7K | ﹤0.01% | 3060 |
|
|
2015
Q2 | $347K | Buy |
56,532
+53,695
| +1,893% | +$330K | ﹤0.01% | 3198 |
|
|
2015
Q1 | $23K | Buy |
2,837
+126
| +5% | +$1.02K | ﹤0.01% | 3394 |
|
|
2014
Q4 | $14K | Buy |
2,711
+447
| +20% | +$2.31K | ﹤0.01% | 3554 |
|
|
2014
Q3 | $12K | Buy |
2,264
+145
| +7% | +$769 | ﹤0.01% | 3586 |
|
|
2014
Q2 | $16K | Buy |
+2,119
| New | +$16K | ﹤0.01% | 3467 |
|